HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased serum heat shock protein 27 antibody titers and prooxidant-antioxidant balance in patients with beta-thalassemia major.

AbstractOBJECTIVE:
Determination of the serum heat shock protein 27 (Hsp27) antibody titers and prooxidant-antioxidant balance (PAB) in patients with thalassemia as markers of cell and oxidative stress, respectively.
METHODS:
Serum PAB and anti-Hsp27 antibody titers were measured in 140 patients with thalassemia major and 140 sex- and age-matched healthy volunteers.
RESULTS:
A significantly higher serum PAB value was observed in patients in comparison to controls. In the patient group, anti-Hsp27 antibody titers were significantly higher than for the control group (p < 0.001). We found a weak negative correlation between anti-Hsp27 antibody concentrations and the PAB (p = 0.03), but these values were not correlated with serum superoxide dismutase activity in the thalassemic patients.
CONCLUSIONS:
Increased levels of serum PAB and Hsp27 antibodies may be involved in the pathological consequences of β-thalassemia major and may contribute to the development of endothelial injury.
AuthorsElham Ghahremanlu, Abdollah Banihashem, Hamidreza Saber, Shima Tavallaie, Naghmeh Mirhosseini, Majid Ghayour-Mobarhan, Gordon A A Ferns
JournalActa haematologica (Acta Haematol) Vol. 129 Issue 1 Pg. 1-9 ( 2013) ISSN: 1421-9662 [Electronic] Switzerland
PMID22964881 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 S. Karger AG, Basel.
Chemical References
  • Antibodies
  • Antioxidants
  • HSP27 Heat-Shock Proteins
  • Oxidants
  • Superoxide Dismutase
Topics
  • Adolescent
  • Antibodies (blood)
  • Antioxidants (metabolism)
  • Child
  • Demography
  • Female
  • HSP27 Heat-Shock Proteins (immunology)
  • Humans
  • Male
  • Oxidants (blood)
  • Superoxide Dismutase (metabolism)
  • Young Adult
  • beta-Thalassemia (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: